If you have kidney disease, a sermorelin intake should include that history before a prescription decision or a long purchase commitment. Include a past kidney injury, dialysis, a transplant, and the clinicians already managing your care. A brief question about general health may not capture the details.
The kidney guidance reviewed here supports careful medication planning and ongoing kidney care. It does not establish that compounded sermorelin improves kidney disease, prove it is safe for every kidney condition, or supply a reliable renal dose adjustment.
Bring your kidney history and medication list into the decision. Do not create a lower dose from a generic online chart.
Start with the kidney diagnosis you actually have
A past kidney stone, a recent kidney injury, and chronic kidney disease are not interchangeable descriptions. Tell the prescriber what your usual clinician has diagnosed, whether it has changed, and whether a kidney specialist is involved. If you do not know the details, ask for help obtaining the relevant records.
The purpose is to make the proposed treatment decision fit your medical situation. It is not to label every kidney-related history as a permanent contraindication. The consultation checklist provides a place to organize the diagnosis, current concerns, and questions about alternatives.
Bring results rather than describing them as normal
NIDDK explains that blood-based filtration estimates and urine albumin testing provide different information about kidney health. Ask your care team which recent results should be shared, including their dates. A single number without its context may not explain your current condition.
Do not use an online eGFR threshold to approve yourself for sermorelin. The clinician must interpret your history and results together. Our laboratory guide discusses hormone testing, but an IGF-1 result does not replace assessment of an existing kidney problem.
Include over-the-counter medicines and supplements
NIDDK recommends discussing medicines with the care team and pharmacist when kidney disease is part of the picture. Include prescriptions from every practice, pain relievers, vitamins, herbal products, and any other peptides. Bring names and amounts rather than simply saying you take a supplement.
Some common pain medicines have kidney-specific risks, particularly in certain illnesses or dehydration. That general guidance is not evidence that sermorelin has the same risk profile. The interaction guide explains why a complete medication review is more useful than assuming an unlisted combination has been proven safe.
Ask what evidence supports this specific proposal
Ask why sermorelin is being considered, what outcome would matter, and what evidence applies to someone with your kidney history. Research on a different growth hormone treatment or a different population should not be treated as a trial of the compounded preparation offered to you.
FDA does not review compounded drugs for safety, effectiveness, or quality before marketing in the same way it reviews approved drugs. We have not identified a validated kidney-adjustment schedule in the sources used for this guide. Taking half of an internet dose is not a substitute for an appropriate prescribing decision.
Coordinate with the team already following your kidneys
Ask the proposed prescriber and your usual clinician how they will share information and decide whether specialist input is needed. People receiving dialysis or transplant care should make those care relationships visible at the outset; this article does not provide a protocol for either setting.
Clarify who would interpret new symptoms or laboratory changes and how to contact them. A commercial treatment plan should not displace established kidney care. The provider-switching guide has useful questions about records and continuity when more than one practice is involved.
Set a follow-up plan before a shipment arrives
Discuss what to do if you become ill, cannot keep fluids down, or notice a concerning change. Follow your own kidney team's instructions about medicines and fluids; generic advice to drink more water may not fit everyone. Ask which symptoms require prompt assessment rather than waiting for a routine portal reply.
Do not assume a new symptom is an expected adjustment to sermorelin or change several medicines yourself. Our side-effect guide helps frame a report to the prescriber. The priority is evaluating the change in the context of your whole health history.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- NIDDK: Managing chronic kidney diseaseGovernment or medical organization guidance · Ongoing kidney care; no evidence of sermorelin benefit or dosing supplied. Checked September 22, 2026.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- NIDDK: Chronic kidney disease tests and diagnosisGovernment or medical organization guidance · GFR and urine albumin measure different aspects of kidney health. Checked September 22, 2026.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
- NIDDK: Keeping kidneys safe with medicinesGovernment or medical organization guidance · General kidney disease medication planning, not sermorelin renal dosing guidance. Checked September 22, 2026.
- FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
- HHS: your medical recordsUS government · Patient access and correction rights; not a guarantee of prescription transfer or continuation. Checked September 21, 2026.